MustafaANoorMDFACP

PubMed

• 149 citations
  The effects of HIV protease inhibitors atazanavir and lopinavir/ritonavir on insulin sensitivity in HIV-seronegative healthy adults.
  Mustafa A. Noor, Rex A. Parker, Edward O'Mara, Dennis M. Grasela, Alexander Currie
  AIDS. 2004-11-05
• 69 citations
  Effects of recombinant human growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation.
  Jean-Marc Schwarz, Kathleen Mulligan, Jeongae Lee, Joan C. Lo, Michael Wen
  The Journal of Clinical Endocrinology and Metabolism. 2002-02-01
• 94 citations
  The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation.
  Joan C. Lo, Kathleen Mulligan, Mustafa A. Noor, Jean-Marc Schwarz, Robert A. Halvorsen
  The Journal of Clinical Endocrinology and Metabolism. 2001-08-01

Journal Articles

• The role of protease inhibitors in the pathogenesis of HIV-associated insulin resistance: cellular mechanisms and clinical implications  
  Noor MA, Current HIV/AIDS Report, 1/1/2007
• The Effects of Atazanavir/ritonavir and Lopinavir/ritonavir on Insulin Sensitivity: Demonstrable Differences in vitro and Clinically  
  Noor MA, Flint OP, Maa J and Parker RA, AIDS, 1/1/2006
• Endoplasmic Reticulum Stress Links Dyslipidemia to Inhibition of Proteasome Activity and Glucose Transport by HIV Protease Inhibitors  
  Parker RA, Flint OP, Mulvey R, Elosua C, Wang F, Fenderson W, Yang WP and Noor MA, Molecular Pharmacology, 1/1/2005
• The Effects of HIV Protease Inhibitors Atazanavir and Lopinavir/ritonavir on Insulin Sensitivity in Healthy Adults  
  Noor MA, Parker RA, Grasela D, O’Mara E, Currie A, Hodder SL, Fiedorek F and Haas, DW, AIDS, 1/1/2004
• The Metabolic Effects of lopinavir/ritonavir in HIV-negative Men  
  Lee, GA, Seneviratne, T, Noor, MA; Lo, JC, Schwarz, JM, Aweeka, FT, Mulligan, K, Schambelan, M, Grunfeld, C, AIDS, 1/1/2004
• Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: A randomized, placebo controlled study  
  Noor MA, Seneviratne T, Aweeka FT, Lo JC, Schwarz JM, Schambelan M, Grunfeld C, AIDS, 1/1/2002
• Effects of growth hormone on hepatic lipid and carbohydrate metabolism in HIV-infected patients with fat accumulation  
  Schwarz JM, Mulligan K, Lee J, Lo JC, Wen M, Noor MA, Grunfeld C and Schambelan M, J Clinical Endocrinology and Metabolism., 1/1/2002
• The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation  
  Lo JC, Mulligan K, Noor MA, Schwarz JM, Halvorsen R, Grunfeld C, Schambelan M, J Clinical Endocrinology and Metabolism, 1/1/2001
• Metabolic Effects of Indinavir in Healthy HIV Seronegative Men  
  Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen R, Schambelan M, Grunfeld C, AIDS, 1/1/2001
• Infection and Inflammation Induce LDL Oxidation in vivo  
  Memon R, Staprans I, Noor M, Holleran W, Uchida Y, Moser AH, Feingold KR, Grunfeld, C, Arter. Thromb Vasc Biol, 1/1/2000
• Paget’s Disease: Review and Update  
  Noor M, Shoback, D, Current Opinion in Rheumatology, 1/1/2000
• Acquired Sulfhemoglobinemia, an Underreported Diagnosis?  
  Noor M, Beutler E, West J Med, 1/1/1998
• Body Fat and Other Metabolic Effects of Atazanavir and Efavirenz, Each Administered in Combination With Zidovudine Plus Lamivudine, in Antiretroviral-naive HIV-infecte...  
  Jemsek JG, Arathoon E, Arlotti M, Perez C, Sosa N, Pokrovskiy V, Thiry A, Soccodato M, Noor MA, Giordano M, Clin Infect Dis., 1/15/2006
• HIV Protease Inhibitors Increase Adiponectin Levels in HIV-Negative Men  
  Lee GA, Mafong DD, Noor MA, Lo JC, Mulligan K, Schwarz JM, Schambelan M, Grunfeld C, J Acquir Immune Defic Syndr., 1/20/2004
• Glycemic control with glyburide/metformin tablets in combination with rosiglitazone in patients with type 2 diabetes: a randomized, double-blind trial  
  Dailey GE 3rd, Noor MA, Park JS, Bruce S, Fiedorek FT., Am J Med, 1/15/2004
• Join now to see all

Abstracts/Posters

• The Effect of atazanavir vs. lopinavir/ritonavir on insulin-stimulated glucose disposal rate in healthy subjects
  Noor MA, Grasela D, Parker R, Chaudhari U, Uderman H, Currie A, Agarwala S, Grunfeld C, Giordano M, Hodder S, Fiedorek F and O’Mara E, 11th Conference on Retroviruses and Opportunistic Infections, San Francisco, CA, 1/1/2004
• Indinavir increases hepatic glucose production in healthy HIV-negative men
  Noor MA, Park S, Lee GA, Schwarz JM, Lee J, Wen M, Lo JC, Mulligan K, Schambelan M and Grunfeld C, 5th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Antiviral Therapy, Paris, France, 1/1/2003
• HIV protease inhibitors and the Hepatic Metabolome
  Flint OP, Elosua C, Parker RA, Hamilton CM., Noor MA, 13th Conference on Retroviruses and Opportunistic Infections, Denver, CO
• Evaluation of Insulin Sensitivity in Healthy Volunteers Treated with Low-Dose Ritonavir Combined with Atazanavir or Lopinavir: A Randomized, prospective Study Using Hy...
  Noor MA, Maa J, Parker RA, Flint OP, Witek J, Hodder SL, 7th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Dublin, Ireland, 1/13/2005
• Comparative effects of atazanavir versus other HIV protease inhibitors on glucose and amino acid stimulated insulin secretion
  Flint OP, Lubinski J, Parker RA and Noor MA, International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Dublin, Ireland, 1/13/2005
• Characterization of HIV Protease Inhibitors Using large Scale Metablomics of an Adipocyte Cell Model In vitro
  Flint OP, Mulvey R, Wang S, Elosua C, Wang F, Parker RA, Hamilton CM and Noor MA, 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment, Rio de Janeiro, Brazil, 1/24/2005
• Comparative Effects of HIV Protease Inhibitors on Glucose Uptake in Primary Cultures of Rat, Mouse and Human Adipocytes
  Flint OP, Mulvey R, Wang S, Elosua C, Wang F, Parker RA and Noor MA, The Endocrine Society’s 87th Annual Meeting, Endo, San Diego CA, 1/4./2005
• The Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz Suppresses Lipogenic Pathways Both in Adipocyte and Hepatocyte Cell Models in vitro
  Flint OP, Mulvey R, Wang S, Elosua C, Wang F, Parker RA and Noor MA, 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA, 1/22/2005
• Comparative Effect of Atazanavir Alone and in Combination with Low Concentration of Ritonavir on Triglyceride and Cholesterol Synthesis in vitro
  Noor MA, Mulvey R, Wang S, Elosua C, Wang F, Parker RA, Flint OP, 6th International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Washington, DC, 1/25/2004
• A Comparison of Resting Energy, Substrate Oxidation Rates and Endogenous Glucose Production in HIV-negative Subjects After Short-term Treatment with Atazanavir (ATV) o...
  Noor MA, Maa JF, RA parker, OP Flint, Giordano MF, Hodder SL, 44th Interscience Conference on Antimicrobial Agents and Chemotherapy, Washington, DC, 1/30/2004
• Maintenance of favorable in vitro metabolic profile of atazanavir when combined with low dose ritonavir
  Noor MA, Mulvey R, Wang S, Elosua C, Wang F, Parker RA, Flint OP, The XV International AIDS Conference, Bangkok, Thailand, 1/11/2004
• HIV protease inhibitor indinavir acutely inhibits insulin-stimulated glucose disposal: A randomized, placebo-controlled study
  Noor MA, Seneviratne T, Lo JC, Aweeka F, Mulligan K, Schwarz JM, Schambelan M, Grunfeld, C, 3rd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Athens, Greece
• Metabolic Effects of Indinavir in Healthy HIV Seronegative Men
  Noor MA, Lo JC, Mulligan K, Schwarz JM, Halvorsen R, Schambelan M, Grunfeld, C, Second International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV, Toronto, Canada
• Join now to see all

Lectures

• Metabolic Mechanism of Protease Inhibitor-Induced Insulin Resistance and Dyslipidemia 
  Brown University Miriam Hospital, Providence, RI - 1/1/2005
• Metabolic Profile of HIV Protease Inhibitors – Mechanisms and Insights 
  Multiple locations - 1/1/2005
• Metabolic Profile of HIV Protease Inhibitors – An Endocrinologist’s Perspective 
  St. Vincent’s Hospital, New York, NY - 1/1/2005
• Metabolic Profile of HIV Protease Inhibitors 
  Multiple locations - 1/1/2005
• HIV Protease Inhibitors Metabolic Profile 
  Brigham & Women’s Hospital, 2004; Quebec General Hospital, Quebec, Canada, 2004 - 1/1/2004
• Metabolic Profile of HIV Protease Inhibitors: Review of Mechanisms and Clinical Correlates 
  Kaiser Permanente Medical Center, Oakland, California, 2004; Harbor-UCLA Medical Center, 2004 - 1/1/2004
• Protease Inhibitors and Insulin Resistance 
  Marbella, Spain - 1/1/2002
• Indinavir and Insulin Resistance 
  Cannes, France - 1/1/2001
• Join now to see all